SYDNEY, Australia: Antisense Therapeutics Limited (ANP) announced that following his significant tenure as the Company’s Chief Executive Officer and Managing Director (CEO), Mark Diamond has advised that he is retiring as CEO. Mark will continue his responsibilities as CEO until a successor is appointed. ANP Chair, Dr Charmaine Gittleson commented, “On behalf of the ANP…